SPARC (NSE: SPARC; BSE: 532872) is a biopharmaceutical company continuously innovating new therapies in oncology, neurodegeneration, and immunology. SPARC's value proposition lies in our brick-and-mortar infrastructure to effectively translate therapies from the bench, through clinical studies, to... Read more
Cytokinetics
21 followers
Oxford Nanopore Technologies
19 followers
BridgeBio
14 followers
Denali Therapeutics
11 followers
Serum Institute of India Pvt. Ltd.
9 followers
AbCellera
9 followers
Novotech
8 followers
Axsome Therapeutics
8 followers
Cerus
5 followers
Aldevron
4 followers
Sumitoma Pharma US
3 followers
Quanterix
3 followers